【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Glaucoma
06.1.1 Understanding the Disease
06.1.2 Types of Glaucoma
06.1.3 Etiology
06.1.4 Signs and Symptoms
06.1.5 Diagnosis
06.1.6 Management
06.1.7 Epidemiology
06.2 Dry Eye Syndrome
06.2.1 Understanding the Disease
06.2.2 Types of Dry Eye Syndrome
06.2.3 Causes of Dry Eye Syndrome
06.2.4 Risk Factors of Dry Eye Syndrome
06.2.5 Signs and Symptoms
06.2.6 Diagnosis
06.2.7 Management
06.3 Diabetic Retinopathy
06.3.1 Understanding the Disease
06.3.2 Etiology
06.3.3 Diagnosis
06.3.4 Classification
06.3.5 Epidemiology
06.3.6 Management
06.4 RVO
06.4.1 Understanding the Disease
06.4.2 Types of RVO
06.4.3 Etiology
06.4.4 Diagnosis
06.4.5 Management
06.5 AMD
06.5.1 Understanding the Disease
06.5.2 Stages of AMD
06.5.3 Types of AMD
06.5.4 Etiology
06.5.5 Signs and Symptoms
06.5.6 Diagnosis
06.5.7 Management
06.6 Macular Edema
06.6.1 Understanding the Disease
06.6.2 Etiology
06.6.3 Diagnosis
06.6.4 Management
06.7 Economic Burden of Ophthalmic Diseases
07.Pipeline Analysis
07.1 Pipeline Portfolio: Glaucoma
07.1.1 Rhopressa
07.1.2 Roclatan
07.1.3 Trabodenoson
07.1.4 Lomerizine HCl
07.1.5 Y-39983
07.2 Pipeline Portfolio: Dry Eye Syndrome
07.2.1 Lifitegrast
07.2.2 OPC-12759E
07.2.3 EBI-005
07.3 Pipeline Portfolio: Diabetic Retinopathy
07.3.1 Squalamine
07.3.2 K-115-R/Ripasudil Hydrochloride Hydrate
07.4 Pipeline Portfolio: AMD
07.4.1 Anecortave Acetate (Suspension)
07.4.2 E10030
07.4.3 Abicipar
07.5 Pipeline Portfolio: RVO
07.5.1 TLC399
07.5.2 AGN208397
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Disease Type
09.1 Global Ophthalmic Therapeutics Market by Disease Type
09.2 Glaucoma
09.3 Dry Eye Syndrome
09.4 Retinal Disorders
09.4.1 Diabetic Retinopathy
09.4.2 Macular Edema
09.4.3 AMD
09.4.4 RVO
09.5 Global Glaucoma Therapeutics Market
09.5.1 Market Size and Forecast
09.6 Global AMD Therapeutics Market
09.6.1 Market Size and Forecast
09.7 Global Macular Edema Therapeutics Market
09.7.1 Market Size and Forecast
09.8 Global Dry Eye Syndrome Therapeutics Market
09.8.1 Market Size and Forecast
09.9 Global Diabetic Retinopathy Therapeutics Market
09.9.1 Market Size and Forecast
09.10 Global RVO Therapeutics Market
09.10.1 Market Size and Forecast
10.Market Segmentation by Route of Administration
10.1 Topical
10.2 Systemic
10.2.1 IV
10.2.2 Oral
10.3 Intravitreal
11.Market Segmentation by Molecule Type
11.1 Biologics
11.2 Small Molecules
12.Market Segmentation by Dosage Form
12.1 Solutions
12.2 Implants
12.3 Pills
13.Geographical Segmentation
13.1 Global Ophthalmic Therapeutics Market by Geography 2014-2019
14.Buying Criteria
15.Market Growth Drivers
16.Drivers and Their Impact
17.Market Challenges
18.Impact of Drivers and Challenges
19.Market Trends
20.Trends and Their Impact
21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 Novartis
21.2.2 Actavis
21.2.3 F. Hoffmann-La Roche
21.2.4 Regeneron Pharmaceuticals
21.2.5 Bayer
21.2.6 Pfizer
21.2.7 Merck
21.3 Other and Future Prominent Vendors
22.Key Vendor Analysis
22.1 Actavis
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
22.1.4 Business Segmentation by Revenue 2012 and 2013
22.1.5 Sales by Geography
22.1.6 Business Strategy
22.1.7 Key Information
22.1.8 SWOT Analysis
22.2 Bayer
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation by Revenue 2014
22.2.4 Business Segmentation by Revenue 2013 and 2014
22.2.5 Geographical Segmentation by Revenue 2014
22.2.6 Business Strategy
22.2.7 Recent Developments
22.2.8 SWOT Analysis
22.3 F. Hoffmann-La Roche
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Segmentation by Revenue 2012 and 2013
22.3.5 Sales by Geography
22.3.6 Business Strategy
22.3.7 Key Information
22.3.8 SWOT Analysis
22.4 Merck
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
22.5 Novartis
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2012 and 2013
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis
22.6 Pfizer
22.6.1 Key Facts
22.6.2 Business Overview
22.6.3 Business Segmentation by Revenue 2014
22.6.4 Business Segmentation by Revenue 2013 and 2014
22.6.5 Geographical Segmentation by Revenue 2014
22.6.6 Business Strategy
22.6.7 Key developments
22.6.8 SWOT Analysis
22.7 Regeneron Pharmaceuticals
22.7.1 Key Facts
22.7.2 Business Overview
22.7.3 Product Segmentation
22.7.4 Revenue Product Segmentation
22.7.5 Business Strategy
22.7.6 Key Information
22.7.7 SWOT Analysis
23.Other Reports in This Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Major Ophthalmic Conditions
Exhibit 3: Types of Glaucoma
Exhibit 4: Development of Diabetic Retinopathy
Exhibit 5: Classification of Diabetic Retinopathy
Exhibit 6: Types of RVO
Exhibit 7: Types of AMD
Exhibit 8: Global Ophthalmic Therapeutics Market 2014-2019 ($ millions)
Exhibit 9: Global Ophthalmic Therapeutics Market by Disease Type
Exhibit 10: Global Ophthalmic Therapeutics Market by Disease Type 2014
Exhibit 11: Global Glaucoma Therapeutics Market 2014-2019 ($ millions)
Exhibit 12: Key Takeaways: Global Glaucoma Therapeutics Market
Exhibit 13: Global AMD Therapeutics Market 2014-2019 ($ millions)
Exhibit 14: Key Takeaways: Global AMD Therapeutics Market
Exhibit 15: Global Macular Edema Therapeutics Market 2014-2019 ($ millions)
Exhibit 16: Key Takeaways: Global Macular Edema Therapeutics Market
Exhibit 17: Global Dry Eye Syndrome Therapeutics Market 2014-2019 ($ millions)
Exhibit 18: Key Takeaways: Global Dry Eye Syndrome Therapeutics Market
Exhibit 19: Global Diabetic Retinopathy Therapeutics Market 2014-2019 ($ millions)
Exhibit 20: Key Takeaways: Global Diabetic Retinopathy Therapeutics Market
Exhibit 21: Global RVO Therapeutics Market 2014-2019 ($ millions)
Exhibit 22: Key Takeaways: Global RVO Therapeutics Market
Exhibit 23: Global Ophthalmic Therapeutics Market: YoY Growth Rate and Revenue by Disease Type 2014-2019
Exhibit 24: Global Ophthalmic Therapeutics Market by Route of Administration
Exhibit 25: Global Ophthalmic Therapeutics Market by Molecule Type
Exhibit 26: Global Ophthalmic Therapeutics Market by Dosage Form
Exhibit 27: Global Ophthalmic Therapeutics Market by Geography 2014
Exhibit 28: Major Drivers of Global Ophthalmic Therapeutics Market
Exhibit 29: Major Challenges in Global Ophthalmic Therapeutics Market
Exhibit 30: Major Trends in Global Ophthalmic Therapeutics Market
Exhibit 31: Vendor Ranking 2014
Exhibit 32: Novartis: YoY Revenue and Growth Rate of Lucentis 2011-2014 ($ millions)
Exhibit 33: Actavis: YoY Revenue of Restasis 2012-2014 ($ millions)
Exhibit 34: Actavis: YoY Revenue of Lumigan 2012-2014 ($ millions)
Exhibit 35: Actavis: YoY Revenue of Alphagan, Alphagan P, and Combigan 2012-2014 ($ millions)
Exhibit 36: F. Hoffmann-La Roche: YoY Revenue and Growth Rate of Lucentis 2011-2014 ($ millions)
Exhibit 37: Regeneron Pharmaceuticals: YoY Revenue and Growth Rate of Eylea 2011-2014 ($ millions)
Exhibit 38: Bayer: YoY Revenue and Growth Rate of Eylea 2012-2014 ($ millions)
Exhibit 39: Pfizer: YoY Revenue and Growth Rate of Xalatan/Xalacom 2012-2014 ($ millions)
Exhibit 40: Actavis: Business Segmentation 2013
Exhibit 41: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 42: Actavis: Sales by Geography ($ millions)
Exhibit 43: Bayer: Business Segmentation by Revenue 2014
Exhibit 44: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 45: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 46: Business Segmentation of F. Hoffmann-La Roche 2013
Exhibit 47: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 48: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 49: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 50: Merck: Business Segmentation by Revenue 2013
Exhibit 51: Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 52: Merck: Sales by Geography 2013
Exhibit 53: Novartis: Business Segmentation
Exhibit 54: Novartis: Revenue by Business Segmentation 2013
Exhibit 55: Novartis AG: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 56: Novartis: Revenue by Geographical Segmentation 2013
Exhibit 57: Pfizer: Business Segmentation by Revenue 2014
Exhibit 58: Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 59: Pfizer: Geographical Segmentation by Revenue 2014
Exhibit 60: Regeneron Pharmaceuticals: Product Segmentation
Exhibit 61: Regeneron Pharmaceuticals: Revenue Product Segmentation 2013
【レポート販売概要】
■ タイトル:眼科疾患治療薬の世界市場:緑内障、眼球乾燥症候群、網膜障害(糖尿病性網膜症、黄斑浮腫、RVO、AMD)■ 英文:Global Opthalmic Therapeutic Market 2015-2019
■ 発行日:2015年7月22日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6492
■ 調査対象地域:グローバル
- 鍛造プレスの世界市場2017-2021ABSTRACTAbout Forging Presses Forging is a manufacturing process wherein a metal is processed by pressing, pounding, and squeezing it under high pressure, thereby transforming the metal into the size and shape required by customers. Th strength of forged parts is higher than those manufactured using other metalworking processes. Forged parts are used in creating parts of equipment that demand high …
- 2014年イギリスの分子血液型・分類検査および感染症NAT(核酸増幅検査)市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and mar …
- ヘルニア修復の世界市場予測(~2023年)“The hernia repair market projected to grow at a CAGR of 3.0% from 2018 to 2023.” The hernia repair market is projected to reach USD 4.75 billion by 2023 from USD 4.09 billion in 2018, at a CAGR of 3.0%. Factors such as the increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and favorable reimbursement scenario in developed countries are d …
- 肝外胆管がん(Extrahepatic Bile Duct Cancer):世界の治験レビュー(2015年上半期版)Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015" provides data on the Extrahepatic Bile Duct Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Extrahepatic Bile Duct Cancer. It includes an overv …
- セラミックコーティングの世界市場:酸化物コーティング、炭化物コーティング、窒化物コーティングCeramic coatings constitute a large family of materials with quite diverse compositions and properties. They include compositions based on alumina, alumina–magnesia, chromium, silica, silicon carbide, titania, silicon nitride, zirconia, and many others. The global ceramic coatings market is expected to grow at a CAGR of 7.50% from 2015 to 2020 to reach a value of $10.12 billion. One of the key fac …
- Ventricular Tachycardia:グローバル臨床試験レビューH1, 2013Ventricular Tachycardia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, H1, 2013" provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers …
- 外科用ロボットの世界市場分析:製品別(システム、機器およびアクセサリ、サービス)、ブランド別(ダ・ヴィンチ・サージカル・システム、サイバー・ナイフ、ローザ、マコ、ルネサンス)、用途別(泌尿器科、整形外科、脳神経外科、心臓血管、婦人科、放射線科、移植、胃腸)、市場規模別、用途の分析、競争戦略と予測、2016-2024The global surgical robot market is expected to reach USD 20.8 billion by 2024, according to a new study by Grand View Research, Inc. The prevalence of chronic disorders, such as chronic heart diseases and various types of cancer, is on a rise. These diseases frequently require surgery as a line of treatment. With the advent of surgical robot, these surgeries have become easier and less traumatic, …
- Chronic Plaque Psoriasis:グローバル臨床試験レビューH2, 2013Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2013" provides data on the Chronic Plaque Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Plaque Psoriasis. It includes an overview of the trial num …
- 世界の小売産業における在庫管理ソフトウェア市場2016-2020About the Inventory Management Software Market in Retail Sector Inventory is a central asset for a company and represents the investment that is involved from the manufacturing to the sale of the product. Mishandling of inventory can lead to significant financial problems and result in either inventory glut or inventory shortage. An inventory control system is the set of guidelines and controls th …
- 運用支援システム(OSS)/事業支援システム(BSS)ソフトウェアの世界市場About OSS/BSS OSS is a software application that supports back-office activities of a telecom network and maintains customer service. It comprises specialized software that assists telecom companies in network operations and management, service management, and provisioning services. BSS is a software application that supports activities such as customer relationship management (CRM), order managem …
- パラオキシ安息香酸の世界市場Para Hydroxy Benzoic Acid (CAS 99-96-7) Market Research Report 2013 presents comprehensive data on para hydroxy benzoic acid markets globally and regionally (Europe, Asia, North America etc.) The Para Hydroxy Benzoic Acid (CAS 99-96-7) Market Research Report 2013 includes para hydroxy benzoic acid description, covers its application areas and related patterns. It overviews para hydroxy benzoic aci …
- 世界のワイン市場のニュース及びイベント動向(2014年7月)Synopsis The report provides a review of the latest news and key events in the global wine market during July 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global wine market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global wine market …
- タバコの世界市場:シガレット、シガー、シガリロAbout Tobacco Market The Global Tobacco market comprises three major segments: Cigarettes, Cigar and Cigarillos, and Others. Rising prevalence of smoking worldwide coupled with rising disposable income, and increase in female smokers is fueling the growth of the Global Tobacco market. China led the Global Tobacco market in 2013. However, increased demand for e-cigarettes is acting as a major threa …
- エプスタイン・バー(EB)ウイルス感染症ワクチンの世界市場機会分析Epstein-barr virus (EBV) is a herpesvirus family that exclusively infects humans, over 95% of adults worldwide are infected. Primary EBV infections that occur in adolescence or early adulthood often result in infectious mononucleosis (IM), characterized by pharyngitis, cervical lymph node enlargement, fatigue and fever; complications can occur in around 1% of patients. Infectious mononucleosis is …
- 自律型無人潜水機(AUV)の世界市場分析及び予測Autonomous Underwater Vehicles (AUV), also known as unmanned underwater vehicles are used to perform underwater survey missions such as detecting and mapping submerged wrecks, rocks, and obstructions that pose a hazard to navigation for commercial and recreational vessels. The application of autonomous underwater vehicles technology has evolved in the commercial sector where the number of AUVs bei …